Invention Application
- Patent Title: BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE
-
Application No.: US17664609Application Date: 2022-05-23
-
Publication No.: US20220306761A1Publication Date: 2022-09-29
- Inventor: Harald DUERR , Sebastian FENN , Ulrich GOEPFERT , Sabine IMHOF-JUNG , Christian KLEIN , Laurent LARIVIERE , Michael MOLHOJ , Joerg Thomas REGULA , Petra RUEGER , Wolfgang SCHAEFER
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Priority: EP15188067.1 20151002
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P25/00
Abstract:
Herein are provided bispecific anti-human CD20/human transferrin receptor antibodies and methods of using the same.
Public/Granted literature
- US12030952B2 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use Public/Granted day:2024-07-09
Information query
